View in EDS HTML Full Text PDF Full Text

Comparative Cancer Risk in Patients With Psoriasis Treated With Adalimumab, Secukinumab, or Ustekinumab.

Saved in:
Bibliographic Details
Title: Comparative Cancer Risk in Patients With Psoriasis Treated With Adalimumab, Secukinumab, or Ustekinumab.
Authors: Schwarz CW; Department of Dermatology and Allergy, Copenhagen University Hospital-Herlev and Gentofte, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Copenhagen Research Group for Inflammatory Skin, Herlev and Gentofte Hospital, Copenhagen, Denmark., Rasmussen MK; Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark., Bertelsen T; Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.; Health Institute, Aarhus University, Aarhus, Denmark., Iversen L; Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark., Skov L; Department of Dermatology and Allergy, Copenhagen University Hospital-Herlev and Gentofte, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Loft N; Department of Dermatology and Allergy, Copenhagen University Hospital-Herlev and Gentofte, Copenhagen, Denmark.
Source: JAMA dermatology [JAMA Dermatol] 2025 Dec 01; Vol. 161 (12), pp. 1289-1291.
Publication Type: Journal Article
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41123909
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Comparative Cancer Risk in Patients With Psoriasis Treated With Adalimumab, Secukinumab, or Ustekinumab.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Schwarz+CW%22">Schwarz CW</searchLink>; Department of Dermatology and Allergy, Copenhagen University Hospital-Herlev and Gentofte, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Copenhagen Research Group for Inflammatory Skin, Herlev and Gentofte Hospital, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Rasmussen+MK%22">Rasmussen MK</searchLink>; Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.<br /><searchLink fieldCode="AU" term="%22Bertelsen+T%22">Bertelsen T</searchLink>; Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.; Health Institute, Aarhus University, Aarhus, Denmark.<br /><searchLink fieldCode="AU" term="%22Iversen+L%22">Iversen L</searchLink>; Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.<br /><searchLink fieldCode="AU" term="%22Skov+L%22">Skov L</searchLink>; Department of Dermatology and Allergy, Copenhagen University Hospital-Herlev and Gentofte, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Loft+N%22">Loft N</searchLink>; Department of Dermatology and Allergy, Copenhagen University Hospital-Herlev and Gentofte, Copenhagen, Denmark.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101589530%22">JAMA dermatology</searchLink> [JAMA Dermatol] 2025 Dec 01; Vol. 161 (12), pp. 1289-1291.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101589530 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2168-6084 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221686068%22">21686068 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Dermatol <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41123909
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1001/jamadermatol.2025.3928
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1289
    Titles:
      – TitleFull: Comparative Cancer Risk in Patients With Psoriasis Treated With Adalimumab, Secukinumab, or Ustekinumab.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Schwarz CW
      – PersonEntity:
          Name:
            NameFull: Rasmussen MK
      – PersonEntity:
          Name:
            NameFull: Bertelsen T
      – PersonEntity:
          Name:
            NameFull: Iversen L
      – PersonEntity:
          Name:
            NameFull: Skov L
      – PersonEntity:
          Name:
            NameFull: Loft N
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2025 Dec 01
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2168-6084
          Numbering:
            – Type: volume
              Value: 161
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: JAMA dermatology
              Type: main
ResultId 1